Bay Labs has partnered with Northwestern Medicine to assess the artificial intelligence (AI) based EchoGPS cardiac ultrasound guidance software suite for the detection of heart disease through cardiovascular imaging.
The ‘Seeing the Heart with AI Powered Echo’ (SHAPE) study has started enrolling patients. It will recruit a total of 1,200 participants across Northwestern Medicine sites.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
EchoGPS is investigational software in an ultrasound system and leverages AI to help capture echocardiograms by providing real-time guidance to gain cardiac views.
The software suite also includes EchoMD, which has been designed to enable automated review of acquired images.
SHAPE study’s primary objective is to determine whether the EchoGPS software can be used by certified medical assistants (CMAs) without any previous experience to capture quality echocardiograms.
The study will further evaluate if the echocardiogram images can be examined by cardiologists using EchoMD software to detect certain types of heart disease in patients aged 65 years and above, during routine physical examinations in a primary care setting.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataBay Labs co-founder and CEO Charles Cadieu said: “The EchoGPS and EchoMD product suite has the potential to transform how cardiovascular care can be delivered in healthcare systems.
“Incorporating our AI software with deep-learning technology into clinical practice could allow non-specialist medical professionals to acquire images to support cardiologist interpretation and clinical decision-making and may lead to improved patient outcomes through earlier detection and monitoring.”
The study is part of an ongoing Bay Labs and Northwestern Medicine collaboration focused on devising new techniques for the use of AI in clinical cardiovascular care.
It is also in line with Northwestern Medicine’s initiative to leverage AI for the study and treatment of cardiovascular disease.
